Vancomycin Hydrochloride is a tricyclic glycopeptide antibiotic that inhibits bacterial cell-wall peptidoglycan synthesis, remaining a critical last-line therapy against methicillin-resistant Staphylococcus aureus (MRSA) and other multidrug-resistant Gram-positive organisms. Its narrow therapeutic window makes precise potency and impurity characterisation non-negotiable for manufacturers. Simson Pharma supplies a rigorously tested Vancomycin Hydrochloride reference standard alongside its compendial impurities for stability-indicating method development.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Vancomycin Hydrochloride Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.